Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
central nervous system
Biotech
With 4 remaining staffers, CNS-focused Trevena nears end of road
Trevena has whittled its team down to four people, saying goodbye to several C-suite execs amid a strategic review that includes possibly winding down.
Gabrielle Masson
Nov 7, 2024 10:40am
Medidata boosts CNS trials with Cogstate's cognitive assessments
Oct 29, 2024 2:40pm
Newron schizophrenia add-on improves positive, negative symptoms
Apr 30, 2024 9:13am
ProJenX ALS drug gets back on the map after partial FDA hold
Mar 29, 2024 10:44am
Headlands acquires Pharmasite to expand mental health trials
Feb 29, 2024 4:20pm
Alto Neuroscience preps IPO to push CNS therapies through clinic
Jan 16, 2024 6:51am
